Bruce D. Jackson
Stock Analyst at Benchmark
(2.84)
# 2,524
Out of 5,008 analysts
4
Total ratings
100%
Success rate
21%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Bruce D. Jackson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RVPH Reviva Pharmaceuticals Holdings | Maintains: Speculative Buy | $14 → $7 | $0.67 | +948.85% | 1 | Sep 15, 2025 | |
| UNCY Unicycive Therapeutics | Maintains: Speculative Buy | $3 → $21 | $4.72 | +344.92% | 1 | Sep 15, 2025 | |
| HBIO Harvard Bioscience | Maintains: Speculative Buy | $3 → $2 | $0.44 | +353.82% | 1 | Sep 10, 2025 | |
| CLNN Clene | Maintains: Buy | $33 → $31 | $9.20 | +236.80% | 1 | Sep 10, 2025 |
Reviva Pharmaceuticals Holdings
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $14 → $7
Current: $0.67
Upside: +948.85%
Unicycive Therapeutics
Sep 15, 2025
Maintains: Speculative Buy
Price Target: $3 → $21
Current: $4.72
Upside: +344.92%
Harvard Bioscience
Sep 10, 2025
Maintains: Speculative Buy
Price Target: $3 → $2
Current: $0.44
Upside: +353.82%
Clene
Sep 10, 2025
Maintains: Buy
Price Target: $33 → $31
Current: $9.20
Upside: +236.80%